SurModics, Inc.  

(Public, NASDAQ:SRDX)   Watch this stock  
Find more results for SRDX
-0.45 (-1.63%)
After Hours: 27.10 0.00 (0.00%)
Feb 22, 4:00PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 27.10 - 27.75
52 week 21.90 - 34.15
Open 27.40
Vol / Avg. 11,300.00/23,796.00
Mkt cap 357.61M
P/E 287.69
Div/yield     -
EPS 0.09
Shares 13.20M
Beta 0.81
Inst. own 86%
Feb 21, 2018
Surmodics Inc Annual Shareholders Meeting - Webcast
Feb 14, 2018
SurModics Inc Annual Shareholders Meeting (Estimated)
Feb 8, 2018
Q1 2018 Surmodics Inc Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '17) 2017
Net profit margin -2.09% 5.37%
Operating margin -3.72% 9.72%
EBITD margin - 17.31%
Return on average assets -1.05% 2.91%
Return on average equity -1.29% 3.60%
Employees 257 -
CDP Score - -


9924 W 74th St
EDEN PRAIRIE, MN 55344-3523
United States - Map
+1-952-5007000 (Phone)
+1-952-5007001 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Surmodics, Inc. is a provider of medical device and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company's Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices; international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device. The Company's In Vitro Diagnostics segment manufactures or sells components for in vitro diagnostic immunoassay and molecular tests. The In Vitro Diagnostics segment manufactures and sells surface coatings to the diagnostic, biomedical research and life science markets. In Vitro Diagnostics segment offers protein stabilization reagents, substrates, antigens and surface coatings.

Officers and directors

Susan E. Knight Independent Chairman of the Board
Age: 63
Bio & Compensation  - Reuters
Gary R. Maharaj President, Chief Executive Officer, Director
Age: 54
Bio & Compensation  - Reuters
Andrew D. C. LaFrence Chief Financial Officer , Vice President - Finance and Information Systems
Age: 54
Bio & Compensation  - Reuters
Thomas A. Greaney Chief Operating Officer - Medical Devices
Age: 51
Bio & Compensation  - Reuters
Bryan K. Phillips Senior Vice President - Legal and Human Resources, General Counsel & Secretary
Age: 46
Bio & Compensation  - Reuters
Charles W. Olson Senior Vice President - Commercial and Business Development, Medical Devices
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Joseph J. Stich Vice President, General Manager - In Vitro Diagnostics
Age: 52
Bio & Compensation  - Reuters
Timothy J. Arens Vice President - Corporate Development and Strategy
Age: 50
Bio & Compensation  - Reuters
Gregg S. Sutton Vice President - Research and Development, Medical Devices
Age: 58
Bio & Compensation  - Reuters
Jose H. Bedoya Independent Director
Age: 61
Bio & Compensation  - Reuters